Elevance Health (ELV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Elevance Health (ELV) publicó su última previsión de julio 15, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de para el período.
En comparación con la previsión anterior, Elevance Health mantenido redujo su previsión de BPA desde un rango anterior de $30 - $30.
Elevance Health ha emitido 12 actualizaciones de orientación entre el enero 25, 2023 y el noviembre 10, 2025. During this period, the company raised its outlook 1 time and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.20 | $10.74 | $3.10 | $4.96 |
| Actual | $7.45 | $12.58 | $3.33 | $6.03 |
| Surprise | +20.2% | +17.1% | +7.42% | +21.6% |
| Revenue | ||||
| Estimate | $48.59B | $47.98B | $49.47B | $49.51B |
| Actual | $49.83B | $49.49B | $49.31B | $50.09B |
| Surprise | +2.54% | +3.15% | -0.32% | +1.17% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $4.69 | $2.55 | $11.95 | $7.66 |
| Revenue | ||||
| Consensus | $49.02B | $48.04B | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $7.45 | $6.20 | 20.2 % |
| Q1 | Apr 22, 2026 | $12.58 | $10.74 | 17.1 % |
| Q4 | Jan 28, 2026 | $3.33 | $3.10 | 7.42 % |
| Q3 | Oct 21, 2025 | $6.03 | $4.96 | 21.6 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $49.83B | $48.59B | 2.54 % |
| Q1 | Apr 22, 2026 | $49.49B | $47.98B | 3.15 % |
| Q4 | Jan 28, 2026 | $49.31B | $49.47B | -0.32 % |
| Q3 | Oct 21, 2025 | $50.09B | $49.51B | 1.17 % |